Gemcitabine Direct Electrochemical Detection from Pharmaceutical Formulations Using a Boron-Doped Diamond Electrode
暂无分享,去创建一个
C. Cristea | M. Tertiș | R. Sandulescu | I. Tomuță | I. Rus | A. Pusta | C. Barbălată
[1] K. Ohyama,et al. Determination of Gemcitabine in Plasma of Bladder Cancer Patients by Hydrophilic Interaction Chromatography with Ultraviolet Detection. , 2020, Journal of chromatographic science.
[2] S. Krishnan,et al. Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. , 2020, Journal of drug delivery science and technology.
[3] A. Kermanpur,et al. Electrochemical molecularly bioimprinted siloxane biosensor on the basis of core/shell silver nanoparticles/EGFR exon 21 L858R point mutant gene/siloxane film for ultra-sensing of Gemcitabine as a lung cancer chemotherapy medication. , 2019, Biosensors & bioelectronics.
[4] A. Borowsky,et al. Tumor-specific delivery of gemcitabine with activatable liposomes. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[5] Y. Yeo,et al. Development of Liposomal Gemcitabine with High Drug Loading Capacity. , 2019, Molecular pharmaceutics.
[6] Jf Yang,et al. Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC , 2019, Cellular & Molecular Biology Letters.
[7] Wei Zhang,et al. Boron-doped diamond: current progress and challenges in view of electroanalytical applications , 2019, Analytical Methods.
[8] M. Locatelli,et al. Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography‐diode array detector , 2018, Journal of pharmaceutical and biomedical analysis.
[9] G. Esendagli,et al. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. , 2017, International journal of pharmaceutics.
[10] Gözde Aydoğdu Tığ,et al. Electrochemical DNA biosensor based on poly(2,6-pyridinedicarboxylic acid) modified glassy carbon electrode for the determination of anticancer drug gemcitabine. , 2016, Talanta.
[11] E. Giovannetti,et al. Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective , 2016, Cancer Chemotherapy and Pharmacology.
[12] Keerti Jain,et al. Controlled delivery of Gemcitabine Hydrochloride using mannosylated poly(propyleneimine) dendrimers , 2015, Journal of Nanoparticle Research.
[13] N. Jaffrezic‐Renault,et al. Anticancer drug detection using a highly sensitive molecularly imprinted electrochemical sensor based on an electropolymerized microporous metal organic framework. , 2015, Talanta.
[14] A. Shakya,et al. Stability-Indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations , 2015, International journal of analytical chemistry.
[15] K. M. Naik,et al. Electro-oxidation and determination of gemcitabine hydrochloride, an anticancer drug at gold electrode , 2013 .
[16] Nagappa L. Teradal,et al. Electrochemical investigations of an anticancer drug in the presence of sodium dodecyl sulfate as an enhancing agent at carbon paste electrode , 2012, Journal of Applied Electrochemistry.
[17] Bhoomika R. Mistry,et al. Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[18] S. S. Kalanur,et al. Electrochemical studies and spectroscopic investigations on the interaction of an anticancer drug with DNA and their analytical applications , 2009 .
[19] F. Cappuzzo,et al. Role of gemcitabine in cancer therapy. , 2005, Future oncology.
[20] K. Goa,et al. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. , 1997, Drugs.